Safety, tolerability and clinical implementation of 'ready-to-use' (68)gallium-DOTA0-Tyr3-octreotide ((68)Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
Authors
Manoharan, PrakashLamarca, Angela
Navalkissoor, S
Calero-Valdayo, Juan
Chan, PS
Julyan, Peter J
Sierra, M
Caplin, M
Valle, Juan W
Affiliation
The Christie NHS Foundation Trust, ENETS Centre of Excellence, Manchester, UKIssue Date
2020
Metadata
Show full item recordCitation
Lees-Deutsch L, Gough B, Yorke J, Caress AL. Patient and Caregiver Experience of Hospital Discharge from an Acute Medicine Unit via the Discharge Lounge: A Qualitative Case Study. Acute Med. 2020;19:26-33Journal
ESMO OpenDOI
10.1136/esmoopen-2019-000650PubMed ID
32188715Additional Links
https://dx.doi.org/10.1136/esmoopen-2019-000650Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/esmoopen-2019-000650
Scopus Count
Collections
Related articles
- Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of (68)Ga DOTATOC as Assessed by Dynamic Whole-body PET in Patients with Neuroendocrine Tumors: Implications for Diagnosis and Therapy.
- Authors: Lodge MA, Solnes LB, Chaudhry MA, Wahl RL
- Issue date: 2021 Oct
- Evaluation of [(68)Ga]Ga-DATA-TOC for imaging of neuroendocrine tumours: comparison with [(68)Ga]Ga-DOTA-NOC PET/CT.
- Authors: Yadav D, Ballal S, Yadav MP, Tripathi M, Roesch F, Bal C
- Issue date: 2020 Apr
- Sensitivity Comparison of (68)Ga-OPS202 and (68)Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study.
- Authors: Nicolas GP, Schreiter N, Kaul F, Uiters J, Bouterfa H, Kaufmann J, Erlanger TE, Cathomas R, Christ E, Fani M, Wild D
- Issue date: 2018 Jun
- Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
- Authors: Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C
- Issue date: 2013
- Evaluation of (68)Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with (68)Ga-DOTATOC PET/CT.
- Authors: Sawicki LM, Deuschl C, Beiderwellen K, Ruhlmann V, Poeppel TD, Heusch P, Lahner H, Führer D, Bockisch A, Herrmann K, Forsting M, Antoch G, Umutlu L
- Issue date: 2017 Oct